Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SOP for HPLC System Operation and System Suitability Testing

Posted on November 25, 2025November 25, 2025 By digi


SOP for HPLC System Operation and System Suitability Testing

Comprehensive Tutorial: SOP for HPLC System Operation and System Suitability Testing

High Performance Liquid Chromatography (HPLC) remains a cornerstone analytical technique in pharmaceutical Quality Control (QC) laboratories. Ensuring the consistent, compliant, and precise operation of HPLC systems is central to validated methods and reliable data generation. This step-by-step GMP tutorial guides QC and Quality Assurance (QA) professionals through an effective hplc operation sop focusing on system startup, equilibration, operational parameters, and crucial system suitability testing. It is tailored to meet regulatory expectations across the US, UK, and EU markets, leveraging applicable guidelines including 21 CFR Part 211, EU GMP Annex 15, and PIC/S recommendations.

1. Preparation and Initial Setup of the HPLC System

Executing an effective hplc operation sop begins with thorough preparation and system readiness checks. This phase is critical to ensure analytical accuracy, reproducibility, and compliance with regulatory requirements.

1.1 System Component Verification

  • Inspect the HPLC instrument: Confirm that all components including the solvent delivery system (pump), injection module, column compartment, detector(s), and data acquisition system are intact and clean.
  • Check system logs and maintenance records: Review previous usage, maintenance, and calibration logs per the laboratory’s quality system to verify the system is within its validated state.
  • Cleanliness and leaks: Inspect all tubing, connections, and seals for wear or leaks. Replace parts if necessary to prevent baseline noise or pressure fluctuation.

1.2 Reagent and Mobile Phase Preparation

  • Mobile Phase Preparation: Prepare the mobile phase according to the method SOP using appropriate solvents and buffer concentrations. Use reagent-grade materials compliant with pharmacopoeial specifications.
  • Filtration and Degassing: Filter the mobile phase solutions using a 0.45 μm or finer membrane filter to remove particulates. Degas via helium sparging, vacuum, or sonication to minimize gas bubbles that can disrupt flow and detector signals.
  • Labeling and Storage: Clearly label mobile phase containers with preparation date, expiry, and operator initials. Store in clean, dedicated reservoirs to prevent microbial contamination.

1.3 System Startup and Leak Check

Begin system startup by switching on the HPLC instrument components following manufacturer recommendations. Prime the pumps gradually with mobile phase to avoid air bubbles. Carefully inspect all joints and connections for leaks during initial pressurization. Achieving stable system pressure within method parameters is mandatory before proceeding.

Also Read:  SOP for Preventive Maintenance of Manufacturing Equipment

This preparation step complies with modern GMP expectations that require demonstration of system readiness prior to analytical runs, contributing to data integrity and reproducibility.

2. HPLC System Equilibration and Parameter Settings

System equilibration ensures the chromatographic column and detector reach steady-state operational conditions to generate reproducible chromatograms. This step is vital in establishing baseline stability and avoiding retention time shifts.

2.1 Column Conditioning and Equilibration

  • Column Installation: Install the chromatographic column securely ensuring the correct flow direction as indicated by the manufacturer to preserve column lifetime and functionality.
  • Flush with Mobile Phase: Flush the column at a low flow rate with the mobile phase to remove any storage solvents and stabilize column packing material.
  • Equilibration Time: Allow equilibration by passing mobile phase through the column at method flow rate and temperature until stable baseline absorbance and system pressure are observed. Commonly, this takes at least 30 minutes but should align with method-specific requirements.

2.2 Setting System Parameters

  • Flow Rate: Set the flow rate precisely as per the method SOP, typically controlled via the pump’s digital interface.
  • Column Oven Temperature: Stabilize the temperature to the defined setpoint to control analyte retention and peak shape.
  • Detector Settings: Configure the appropriate wavelength(s), reference wavelength (if applicable), and signal gain. Verify photodiode array or UV detectors are calibrated and warmed up.
  • Injection Volume: Confirm the autosampler or manual injection volume is set precisely, considering the method’s sample preparation SOP.
  • Data Acquisition: Set up acquisition parameters in chromatography software, ensuring method templates are loaded and system clocks are synchronized for audit trail compliance.

Document all parameter settings in the batch record or electronic log. Regulatory inspectors commonly verify adherence to SOPs and data traceability in HPLC QC operations, so meticulous recordkeeping aligned with Annex 15 and FDA expectations is essential.

3. Conducting System Suitability Testing (SST) for HPLC QC

System suitability tests are regulatory prerequisites that verify whether the HPLC system performance is acceptable before analyzing a batch of samples. SST serves as an early warning system, detecting issues that may affect chromatographic resolution, sensitivity, or reproducibility. Without passing SST criteria, analytical runs must not proceed, safeguarding pharmaceutical product quality.

3.1 Selection of System Suitability Samples

System suitability tests commonly utilize reference standards, mixtures mimicking sample matrices, or test solutions per method validation documentation. These standards are representative of critical analytes and impurities, ensuring the entire method’s performance is tested.

Also Read:  SOP for Management of Controlled Documents and Master Lists

3.2 Key SST Parameters and Acceptance Criteria

  • Resolution (Rs): Adequate separation between critical peaks must meet or exceed method-defined thresholds (typically Rs > 2.0).
  • Repeatability (RSD): Relative standard deviation of peak areas from multiple injections should not exceed predefined limits (generally ≤ 2.0%).
  • Tailing Factor (Tf): Peak symmetry must be within limits (usually Tf < 2.0) to confirm no ghost peaks or column degradation.
  • Retention Time (RT): The retention time of standard peaks should be reproducible within narrow tolerances to verify system stability.
  • Plate Count (N): Theoretical plate number evaluation ensures column efficiency is sufficient for valid separations.

Because SST data directly affect batch release decisions, the acceptance criteria must be clearly stated in the SOP and aligned with the validated method and stability study data.

3.3 Performing System Suitability Tests

  1. Inject the SST standard solution as per the injection volume and replicate number defined by the SOP, generally five injections.
  2. Record chromatograms and measure parameters such as peak areas, retention times, tailing factors, and resolution.
  3. Calculate averages, standard deviations, and relative standard deviations according to the SOP’s statistical formulae.
  4. Compare results against the pre-established acceptance criteria.
  5. Document test results in SST logs, lab notebooks, or electronic laboratory notebooks (ELNs) with operator signature, date, and system identifiers.
  6. If SST fails, investigate root causes including system leaks, column deterioration, mobile phase contamination, or incorrect system parameters. No sample analysis should proceed until corrective actions are documented and SST passes.

3.4 Regulatory Compliance and System Suitability

System suitability requirements form a fundamental part of Good Manufacturing Practice (GMP) and are described in regulatory frameworks such as FDA 21 CFR Part 211 and EU GMP Annex 15. Inspectors focus on documented SST procedures, adherence to acceptance criteria, and proper deviation management to confirm system capability before batch analyses.

4. Routine Operation and Data Management in HPLC QC Laboratories

Once system suitability is confirmed, the laboratory can proceed to routine sample analysis following validated methods and SOPs. Consistent operational discipline ensures data integrity, reproducibility, and compliance with pharmaceutical standards.

4.1 Sample Injection and Run Monitoring

  • Follow sample preparation SOPs rigorously to maintain homogeneity and prevent contamination.
  • Inject samples in the prescribed sequence, preferably using autosamplers to minimize manual errors.
  • Monitor chromatograms in real-time for unexpected peak shapes, baseline anomalies, or pressure fluctuations that might indicate system issues.
  • Annotate unusual observations promptly in chromatography system audit trails or batch records.
Also Read:  SOP for Sanitization of Cleanrooms and Controlled Areas

4.2 Data Review and QC Approval

  • Post-run, conduct chromatogram integration and calculation checks to verify peak identification and quantitation accuracy.
  • Confirm that analytical results fall within validated method specifications.
  • Review system suitability parameters for each analytical sequence to confirm ongoing system performance.
  • Document all data reviews, with electronic or handwritten signatures as per GDP and GMP guidelines.
  • Flag and investigate any excursions or out-of-specification (OOS) results according to established laboratory procedures.

4.3 Instrument and Software Maintenance

  • Scheduled maintenance as defined by instrument manufacturers and internal quality systems ensures consistent system reliability.
  • Software systems managing chromatography data must be validated and maintained to prevent data loss or unauthorized access, in accordance with PIC/S and FDA GxP recommendations.
  • Routine calibration of detectors, pumps, and weigh scales is essential to maintain system accuracy.

5. Troubleshooting and Continuous Improvement of HPLC Operations

Operational excellence in hplc qc laboratories depends on proactive troubleshooting and continuous improvement processes embedded within the GMP framework. Identifying, documenting, and correcting deviations facilitate regulatory compliance and method robustness.

5.1 Common HPLC System Issues and Remedies

  • Baseline Noise or Drift: Check mobile phase quality, degassing efficiency, and detector stability. Replace or clean the detector flow cell if necessary.
  • Pressure Fluctuations: Inspect for leaks, blockages, or worn pump seals. Flush lines and replace filters.
  • Poor Peak Shape: Evaluate column condition, injection technique, and mobile phase pH. Consider column regeneration or replacement.
  • Retention Time Shifts: Verify mobile phase composition, temperature control, and flow rate accuracy.

5.2 Documentation of Deviations and CAPA

All deviations from SOPs or SST failures must be documented in deviation logs with thorough root cause analyses and timely corrective and preventive actions (CAPA). These practices ensure ongoing compliance with PIC/S GMP guides and reflect a mature Quality Management System (QMS).

5.3 Training and Competency

Regular training of QC analysts and QA personnel on the hplc operation sop, system suitability interpretation, and troubleshooting techniques enhances laboratory performance and ensures consistent adherence to GMP expectations.

Summary and Final Recommendations

Implementing a rigorous and detailed hplc operation sop with a focus on system equilibration, system suitability testing, and continuous monitoring safeguards the reliability of chromatographic data in pharmaceutical QC laboratories. This tutorial has outlined practical, stepwise instructions aligned with regulatory frameworks across the US, UK, and EU. Observing these practices minimizes analytical risks, supports data integrity, and facilitates regulatory compliance.

By integrating proper preparation, validated system suitability tests, diligent data management, and problem-solving mechanisms, pharmaceutical QC laboratories can maintain robust chromatographic methods essential for drug quality assurance.

HPLC & Chromatography Tags:chromatography, hplc, pharmasop, QC, sop, system suitability

Post navigation

Previous Post: SOP for Line Clearance Prior to Batch Start
Next Post: SOP for Verification of Pharmacopoeial and Compendial Methods

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme